Best Hormone therapy for prostate cancer Hormone therapy for prostate cancer: TOP 32 doctors

The doctor is a highly experienced Turkish medical oncologist specializing in sarcoma, lymphoma, pancreatic, lung cancer, and breast cancer. With over 20 years of experience, the doctor focuses on tumor biology, tumor immunology, cancer immunotherapy, and targeted therapies. Since 2019, the doctor has been serving as a medical oncologist at Anadolu Medical Center and previously held leadership roles at Istanbul Okan University Faculty of Medicine and GATA Haydarpaşa Training Hospital. The doctor has authored over 40 publications in cancer research and is a member of the Turkish Medical Oncology Association and the European Head and Neck Society.

Dr. Eda Tanrikulu ranks among Turkey's top oncologists, with a deep focus on medical oncology and chemotherapy at Anadolu Medical Center.

• Specialized in Medical Oncology from Marmara University
• Completed internal medicine training at Istanbul University
• Ranked 3rd in Turkey's minor specialty exam
• Led medical oncology units in major training hospitals

Dr. Solak specializes in hormone therapy for prostate cancer at Hisar Hospital Intercontinental, with a background from prestigious institutions like Hacettepe University and MD Anderson Cancer Center.

• Trained at Hacettepe University Cancer Institute for oncology specialization
• Worked at The University of Texas MD Anderson Cancer Center
• Experienced in treating various cancers including prostate cancer
• Residency completed at Istanbul Sisli Etfal Training and Research Hospital

The doctor is an Urological Oncologist specializing in Minimal Invasive Surgery, Neo-Bladder Reconstruction, and Urological Cancer at Anadolu Medical Center. With a Bachelor Degree from Istanbul University and a Residency in Urology from Marmara University, the doctor has been recognized with several awards, including the Science Encouragement Award for Residency Students in 2008 and the Young Academic Presentation Award in 2012.

The doctor is an Executive Board Member of the Association of Urooncology and Secretary of the Bladder Tumours Research Group. Additionally, the doctor is a member of the International Bladder Cancer Network, European Association of Urology, and the American College of Surgeons.

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with over 41 years of experience specializing in prostate cancer treatments.

• Associate Professor of Oncology at Tel-Aviv University
• Fellowship-trained in sarcoma and bone oncology at Institut Gustave Roussy, Paris
• Active member of ESMO and ASCO with ongoing research contributions
• Former Chairman of the Israeli Society for Oncology and Radiotherapy

Dr. Sarid specializes in hormone therapy for prostate cancer at Sourasky Medical Center, with extensive experience in oncology treatments.

• Senior oncologist at Sourasky Medical Center since 2009
• Trained in cancer urology at Oxford University
• Principal investigator of clinical trials in cancer therapies
• Member of The European Society for Medical Oncology

Head of Teaching at Puerto Vallarta Regional Hospital with a strong focus on hormone therapy and minimally invasive procedures.

• Specializes in hormone therapy for prostate cancer
• Extensive experience in minimally invasive surgical procedures
• Certified in biomagnetism by the Higher Institute of Biomagnetism
• Skilled in various medical and dermatological treatments

Prof. Zamboglou leads prostate cancer research at Medical Center University of Freiburg, with accolades from the German Society of Radiation Oncology.

• Board-certified in Radiotherapy and Radiation Oncology
• Head of the section 'Interventional Radiation Oncology'
• Recipient of the Herman-Holthusen Award
• Member of ESTRO-ACROP guideline committee for prostate cancer
• Prostate cancer research group leader at university hospital

Abdullah Sakin specializes in hormone therapy for prostate cancer at Medipol Bahçelievler Hospital.

• Head of Medical Oncology Department at Yüzüncü Yıl University
• Trained in medical oncology at Istanbul Okmeydanı Training and Research Hospital
• Experienced in internal medicine with a focus on oncology

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

The doctor specializes in managing breast cancer, colorectal, and urogenital system cancers. With extensive experience since 2014 at Anadolu Medical Center, the doctor has previously served at Medical Park Hospital, Kocaeli Derince Education and Research Hospital, and Erzurum Regional Education and Research Hospital. The doctor's military service included a role as a Medical Oncology specialist at Gülhane Military Medical Academy.

Educational achievements include a degree in general medicine from Istanbul University and specializations in internal medicine and medical oncology. The doctor is a member of the Turkish Medical Association, the Turkish Medical Oncology Society, and the Turkish Lung Cancer Society.

Professor Yesim Yildirim specializes in hormone therapy for prostate cancer at Anadolu Medical Center with 80+ international publications.

• Member of European Society of Medical Oncology (ESMO)
• Expert in cancer immunotherapy and targeted therapies
• Authored co-author in 'Handbook of Advanced Cancer Care Treatment'
• Professor at Halic University, Istanbul

Associate Professor specializing in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings advanced expertise to hormone therapy for prostate cancer at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience across multiple oncology departments
• Promoted to Associate Professor in 2016
• Works at a leading university hospital in Turkey

Chief Physician at BKZ Solingen's certified cancer center – Phd Viola Fox leads innovative hormone therapy programs for prostate cancer.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with molecular diagnostics expertise
• Active researcher in haemato-oncological disease treatments
• Member of German and American oncology societies

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Specializes in hormone therapy for prostate cancer at Medical Park Antalya Hospital Complex. Dr. Alemdar brings extensive training and experience to his practice.

• Board-certified in Medical Oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University Faculty of Medicine
• Works at a leading hospital complex in Antalya

Assoc. Prof. Nail Paksoy specializes in hormone therapy for prostate cancer at Medipol Bahçelievler Hospital, with extensive involvement in cutting-edge clinical trials.

• ESMO board-certified in medical oncology
• Completed fellowship at Istanbul University Oncology Institute
• Participated in 8 international clinical trials
• Published research on PSMA-based tumor burden in prostate cancer

Professor of Medical Oncology with over 29 years of experience of experience – Dr. Cicin specializes in hormone therapy for prostate cancer at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Former Associate Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Associate Professor Muhammed Mustafa Atci specializes in hormone therapy for prostate cancer at İstinye University Liv Hospital Topkapı, combining clinical expertise with academic leadership.

• Board-certified in medical oncology with a focus on prostate cancer treatments
• Active member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed studies on cancer treatment outcomes
• Education Coordinator for Medical Oncology at Prof. Dr. Cemil Taşcıoğlu City Hospital